Abstract:
The present invention relates to the use of a plant extract from the genus Galeopsis species tetrahit or a composition that contains it to stimulate hair growth or improve the appearance or hair fullness. The composition containing the plant extract is applied in both cosmetic and medical-trichological fields and can be applied topically on the scalp or administered orally.
Abstract:
The invention relates to compounds having general formula (I): where R = H, CH 2 -OH, CH 2 -O-CO-CH 3 , CH 2 -O-CO-Ph (Ph=phenyl) R' = H, CH 2 -O-CO-CH 3 , CH 2 -O-CO-Ph (Ph = phenyl) Ar = phenyl, 3-methoxy-4-hydroxy phenyl, 2-furyl. These are compounds having antioxidant activity against free radicals together with anti-inflammatory activity, the compounds being useful as active ingredients for the preparation of pharmaceutical dermatological or cosmetic compositions for skin care.
Abstract:
The present invention relates to polyglycerol-azelaic acid polyesters and cosmetic compositions that incorporate them as active components in combination with a cosmetically acceptable vehicle. In certain aspects the invention also relates to a process for producing esters and polyesters between azelaic acid and glycerol or oligomers thereof containing up to 10 monomer units.
Abstract:
The present invention relates, in one aspect, to an adduct of formula O-PF-A, in which O is an oil; PF is a perfluoropolyether phosphate (PFPE phosphate); A is at least one substance selected from: (X) a water-soluble polyhydroxylated substance and (Y) a water-insoluble inorganic substance and to topical applications thereof in particular in the cosmetic and pharmaceutical field.
Abstract:
The object of the invention is a mixture of catechin and quercetin in a molar ratio varying between 3:1 and 6:1, respectively, for the treatment of the immunosuppression induced in the skin by aggressive agents such as airborne pollutants, dehydrating agents, ultraviolet radiation, and thermal and osmotic shocks, and a pharmaceutical, dermatological, nutritional or cosmetic composition containing said mixture as an active ingredient.
Abstract:
The invention relates to compounds of general formula (I): CH 3 -(CH=CH) n -R (I) wherein n = 3, 5, 7; R is selected from -CO-OR', -CO-O (-) , or -CH 2 -O-CO-R', R' being selected from H, C 1 -C 22 alkyl or alkenyl.aryl or aralkyl, or sugars; with the proviso that when R is -CH 2 -O-CO-R' and R' alkyl, said alkyl being selected from C 1 to C 11 ; and pharmaceutically acceptable salts thereof, preferably such as sodium, potassium, lysine salts, each compound of general formula (I) being used as such or in admixture with one or more of the other ones, for use in the prevention or treatment of skin cancer resulting from DNA damage produced by UV radiation.
Abstract:
In one aspect, the present invention relates to a system for the modified release of one or more active ingredients, comprising a polymeric matrix based on hyaluronic acid with molecular weight ranging from 100 to 100,000 Daltons and a non-ionic polymer which jellifies in contact with water, in which one or more active ingredients are dispersed, optionally in form of microgranules or microcapsules.
Abstract:
The present invention concerns a mixture comprising isoflavones-aglicones, such as daidzein, genistein and glycitein, in addition to equol and lunasin, said mixture being based on soya fermented using lactic acid bacteria isolated from food matrices and use of said mixture for protection of skin and similar and of human intestinal cells with particular reference to prevention of inflammatory state and protection of barrier functions and hair loss treatment.
Abstract:
The object of the present invention is the use of compounds designed to inhibit the activity of the enzyme 5α-reductase. This is a novel use of compounds of general Formula (I): CH 3 (-CH=CH) n -R (I) where n = from 2 to 7, and R is chosen from among: CHO, CH 2 OH, CH 2 O-CO-R', CO-O (-) , where R' is chosen from among H, and the alky from C 1 to C 22 , each compound of general Formula (I) being used as such or in mixtures with other compounds, as the active principle in a pharmaceutical or cosmetic composition designed to inhibit the action of the enzyme 5α-reductase, and of the pharmaceutical or cosmetic compositions deriving therefrom.
Abstract:
The present invention relates to the use of an agent to combat and reduce the irritating action of primary surfactants in compositions to be applied to the skin for care or cleansing of the face and body, characterized in that said agent is chosen from one or more salts of glycyrrhizic acid, such as monoammonium glycyrrhizinate (MAG) and dipotassium glycyrrhizinate (DPG).